Citadel Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-148,280
| Closed | -$259K | – | 14846 |
|
|
2025
Q1 | $259K | Sell |
148,280
-7,278
| -5% | -$9.6K | ﹤0.01% | 9904 |
|
|
2024
Q4 | $246K | Buy |
155,558
+155,526
| +486,019% | +$239K | ﹤0.01% | 10070 |
|
|
2024
Q3 | $50 | Buy |
+32
| New | +$53 | ﹤0.01% | 14101 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 15278 |
|
|
2024
Q1 | – | Sell |
-28,461
| Closed | -$46.4K | – | 15403 |
|
|
2023
Q4 | $36.4K | Buy |
28,461
+16,746
| +143% | +$22.3K | ﹤0.01% | 12094 |
|
|
2023
Q3 | $16.2K | Sell |
11,715
-16,090
| -58% | -$23.3K | ﹤0.01% | 12787 |
|
|
2023
Q2 | $40.9K | Buy |
27,805
+22,019
| +381% | +$29.3K | ﹤0.01% | 12042 |
|
|
2023
Q1 | $4.9K | Sell |
5,786
-36,719
| -86% | -$48.6K | ﹤0.01% | 13918 |
|
|
2022
Q4 | $58.2K | Buy |
+42,505
| New | +$66.8K | ﹤0.01% | 11946 |
|
|
2022
Q3 | – | Sell |
-23,655
| Closed | -$42.6K | – | 13640 |
|
|
2022
Q2 | $49K | Buy |
+23,655
| New | +$57.4K | ﹤0.01% | 11954 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 14559 |
|
|
2021
Q4 | – | Sell |
-3,536
| Closed | -$15.7K | – | 14711 |
|
|
2021
Q3 | $24K | Sell |
3,536
-24,438
| -87% | -$179K | ﹤0.01% | 13621 |
|
|
2021
Q2 | $227K | Buy |
27,974
+25,382
| +979% | +$283K | ﹤0.01% | 11889 |
|
|
2021
Q1 | $40K | Buy |
+2,592
| New | +$38.4K | ﹤0.01% | 12979 |
|
|
2020
Q4 | – | Sell |
-10,880
| Closed | -$56K | – | 11525 |
|
|
2020
Q3 | $56K | Buy |
+10,880
| New | +$71.6K | ﹤0.01% | 9562 |
|
|
2019
Q1 | – | Sell |
-1,067
| Closed | -$10K | – | 9839 |
|
|
2018
Q4 | $10K | Buy |
+1,067
| New | +$17.7K | ﹤0.01% | 8928 |
|
|
2017
Q3 | – | Sell |
-94
| Closed | -$11K | – | 8044 |
|
|
2017
Q2 | $11K | Sell |
94
-167
| -64% | -$27.9K | ﹤0.01% | 7368 |
|
|
2017
Q1 | $52K | Buy |
+261
| New | +$49.7K | ﹤0.01% | 7035 |
|
|
2016
Q4 | – | Sell |
-191
| Closed | -$62.1K | – | 7845 |
|
|
2016
Q3 | $76K | Buy |
191
+50
| +35% | +$20.6K | ﹤0.01% | 6742 |
|
|
2016
Q2 | $49K | Buy |
141
+12
| +9% | +$8.59K | ﹤0.01% | 6414 |
|
|
2016
Q1 | $107K | Sell |
129
-80
| -38% | -$63.6K | ﹤0.01% | 5997 |
|
|
2015
Q4 | $219K | Sell |
209
-392
| -65% | -$393K | ﹤0.01% | 5689 |
|
|
2015
Q3 | $471K | Buy |
601
+427
| +245% | +$438K | ﹤0.01% | 4885 |
|
|
2015
Q2 | $228K | Sell |
174
-208
| -54% | -$336K | ﹤0.01% | 6147 |
|
|
2015
Q1 | $776K | Buy |
382
+352
| +1,173% | +$765K | ﹤0.01% | 4281 |
|
|
2014
Q4 | $57K | Buy |
+30
| New | +$53.4K | ﹤0.01% | 7098 |
|